May 21st: Healthcare Finance and M&A- What Comes Next?

Healthcare funding, financing and M&A have declined for the last two years, currently equivalent to 2020 levels. This trend is more pronounced in Israel. What is the outlook for healthcare funding, financing, and M&A in the next 12 months? On May 21st, join Michael Margolis, R.Ph, Co-Head of Healthcare Investment Banking at Oppenheimer & Co., Sarit Steinberg, Partner, Israel Biotech Fund; Matt Kittay, Head of M&A at Fox Rothschild; and Adam Salkin, M&A Partner at Herzog, for an in-depth look at Healthcare Finance and M&A- What Comes Next?

Date: Tuesday, May 21st
Time: 16:00-17:30
Address: 6 Yitzhak Sadeh, Herzog Tower, 2F, Tel Aviv
Speakers: Michael Margolis, Oppenheimer; Sarit Steinberg, Israel Biotech Fund; Matt Kittay, Fox Rothschild; Adam Salkin, Herzog
Presentation by Oppenheimer & Co: Link HERE
Presentation by Fox Rothschild: Link HERE

Despite headwinds, there are strategies to thrive in this unique financing landscape. See you on May 21st for an in depth look at the dynamics of the Healthcare Financing and M&A market.